Developed by Ionis Pharmaceuticals, Dawnzera is the first RNA-targeted medicine approved for HAE, designed to target plasma ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

The next step for the Rise For Health study researchers is to study the health benefits of frequent standing in older men and ...

Sexual and gender minority individuals still face insurance denials and cost-sharing barriers when accessing pre-exposure ...